Head-to-Head trial tests best way to stop dangerous bleeding disorder

NCT ID NCT01808911

Summary

This completed Phase 3 trial compared two different drug combinations to eliminate harmful antibodies that cause acquired hemophilia, a serious bleeding disorder. The study involved 110 adults with this condition and tested whether steroids with cyclophosphamide work better than steroids with rituximab at removing these antibodies and restoring normal blood clotting. Researchers also tracked side effects like infections and bleeding complications to determine which combination is safer and more effective.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACQUIRED HAEMOPHILIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AP-HM, University Hospital La Conception

    Marseille, 13385, France

  • Europen Hospital of Georges Pompidou (HEGP)

    Paris, 75908, France

  • Hopsital Bretonneau

    Tours, 37044, France

  • Hospital Ambroise Paré

    Boulogne-Billancourt, 92104, France

  • Hospital Archet 1

    Nice, 06202, France

  • Hospital Bichat

    Paris, 75018, France

  • Hospital Cochin

    Paris, 75679, France

  • Hospital Henri Mondor

    Créteil, 94010, France

  • Hospital Jean Verdier

    Bondy, 93140, France

  • Hospital Kremlin-Bicêtre

    Le Kremlin-Bicêtre, 94270, France

  • Hospital Lyon Sud

    Pierre-Bénite, 69495, France

  • Hospital Nord

    Saint-Etienne, 42055, France

  • Hospital Pitié-Salpêtrière

    Paris, 75651, France

  • Hospital Purpan

    Toulouse, 31059, France

  • Hospital Rangueil

    Toulouse, 31059, France

  • Hospital Saint-Louis

    Paris, 75475, France

  • Hospital Sud / Hospital Pontchaillou

    Rennes, 35000, France

  • Hospital of Béziers

    Béziers, 34525, France

  • Regional Center of Haemophilia Treatment (CRTH) de Lorraine

    Nancy, France

  • University Hospital Amiens

    Amiens, 80054, France

  • University Hospital Bocage

    Dijon, 21079, France

  • University Hospital Côte de Nacre

    Caen, 14033, France

  • University Hospital G. Montpied

    Clermont-Ferrand, 63003, France

  • University Hospital Michallon

    Grenoble, 38043, France

  • University Hospital Saint-Eloi

    Montpellier, 34295, France

  • University Hospital of Bordeaux - Hospital Haut-Lévêque

    Pessac, 33604, France

  • University Hospital of Brest - Hospital La cavale Blanche

    Brest, 29609, France

  • University Hospital of Dijon - Hospital Général

    Dijon, 21033, France

  • University Hospital of Nantes, Hospital Hôtel-Dieu

    Nantes, 44093, France

  • University Hospital of Poitiers

    Poitiers, 86021, France

  • University Hospital of Rouen

    Rouen, 76031, France

  • University Regional Hospital Hautepierre

    Strasbourg, 67098, France

  • University Regional Hospital of Lille

    Lille, 59037, France

  • university Hospital of Limoges

    Limoges, 87042, France

Conditions

Explore the condition pages connected to this study.